
Tactile Systems Technology (TCMD) is a Great Momentum Stock: Should You Buy?
Does Tactile Systems Technology (TCMD) have what it takes to be a top stock pick for momentum investors? Let's find out.
Loading news...

Does Tactile Systems Technology (TCMD) have what it takes to be a top stock pick for momentum investors? Let's find out.

Here is how Tactile Systems Technology (TCMD) and Aveanna Healthcare (AVAH) have performed compared to their sector so far this year.

TCMD, SWDBY and NPSNY made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on November 19, 2025.

CNQ stands out in a screen highlighting four stocks with efficiency ratios above industry averages and solid earnings surprise records.

TCMD, NPSNY, SBFG, OPBK and SONY have been added to the Zacks Rank #1 (Strong Buy) List on November 19, 2025.

MINNEAPOLIS, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that management will participate in the Piper Sandler 37th Annual Healthcare Conference, which is being held at the Lotte New York Palace in New York, NY from December 2nd – 4th. Management will participate in a fireside chat on Tuesday, December 2nd at 8:00 a.m. Central Time.

Shares of Tactile Systems Technology, Inc. (NASDAQ: TCMD - Get Free Report) have received a consensus rating of "Moderate Buy" from the six research firms that are covering the firm, MarketBeat reports. Three investment analysts have rated the stock with a hold recommendation, one has issued a buy recommendation and two have assigned a strong buy

Tactile Systems Technology (TCMD) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Tactile Systems Technology Inc (NASDAQ:TCMD) reported upbeat third-quarter earnings and raised FY2025 sales guidance on Monday.

Tactile Systems Technology (TCMD) came out with quarterly earnings of $0.36 per share, beating the Zacks Consensus Estimate of $0.16 per share. This compares to earnings of $0.24 per share a year ago.

Tactile Systems Technology, Inc. ( TCMD ) Q3 2025 Earnings Call November 3, 2025 5:00 PM EST Company Participants Sheri Dodd - CEO, President & Director Elaine Birkemeyer - Chief Financial Officer Conference Call Participants Sam Bentzinger Kyle Edward Winborne - Piper Sandler & Co., Research Division Ryan Zimmerman - BTIG, LLC, Research Division Brandon Vazquez - William Blair & Company L.L.C., Research Division Anderson Schock - B.

MINNEAPOLIS, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results for the third quarter ended September 30, 2025 and announced the adoption of a second share repurchase program. Third Quarter 2025 Summary & Recent Business Highlights: Total revenue increased 17% year-over-year to $85.8 million Gross margin of 76% versus 75% in Q3 2024 Net income of $8.2 million versus $5.2 million in Q3 2024 Adjusted EBITDA of $14.4 million versus $10.7 million in Q3 2024 Announced six-month data demonstrating sustained benefits of Flexitouch® Plus as a first-line therapy in treating lymphedema in head and neck cancer patients Repaid the full outstanding principal balance of $24.0 million under the Company's term loan Authorized a second program to repurchase up to $25.0 million of the Company's common stock “Tactile Medical delivered strong third quarter results, reflecting continued progress across our business transformation and product innovation initiatives”, said Sheri Dodd, Chief Executive Officer of Tactile Medical.

AlphaQuest LLC decreased its holdings in Tactile Systems Technology, Inc. (NASDAQ: TCMD) by 25.2% in the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 18,753 shares of the company's stock after selling 6,331 shares during the quarter. AlphaQuest LLC owned 0.08% of Tactile

MINNEAPOLIS, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced the presentation of new six-month clinical data during the late-breaking poster session at the American Congress of Rehabilitation Medicine (ACRM) 102nd Annual Fall Conference demonstrating sustained clinical benefits of Flexitouch® Plus as a first-line therapy for treating patients with head and neck cancer-related lymphedema.

MINNEAPOLIS, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that third quarter of fiscal year 2025 financial results will be released after the market closes on Monday, November 3, 2025.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.